Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP509970.RAZ6AefDpqyBppp6P87jkZQJ7N-jEeXSonfMclq__gISg130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509970.RAZ6AefDpqyBppp6P87jkZQJ7N-jEeXSonfMclq__gISg130_provenance.
• NP379703.RAuujoApet1JbMCi-We86YWW2mOJSPa6_izgro1Pt8MKc130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379703.RAuujoApet1JbMCi-We86YWW2mOJSPa6_izgro1Pt8MKc130_provenance.
• NP380236.RAm9DKkJ8930zosvUon9T0KTPOLNqHLNsLC8yiNR9GJ8g130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380236.RAm9DKkJ8930zosvUon9T0KTPOLNqHLNsLC8yiNR9GJ8g130_provenance.
• NP653724.RAgEmdP2zLspjeiTbBF4cazF1yq6THwuiwWm56S-cIuZw130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653724.RAgEmdP2zLspjeiTbBF4cazF1yq6THwuiwWm56S-cIuZw130_provenance.
• NP624775.RAqenpbSvXOGS9hl2dAXNQFN_j8Z2H_KcXxA8wV1nCFIg130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624775.RAqenpbSvXOGS9hl2dAXNQFN_j8Z2H_KcXxA8wV1nCFIg130_provenance.
• NP620206.RAaq7WV0VnWmgucT2Kyqb41ntU5MYiBCtFUjPXP8gYGw8130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620206.RAaq7WV0VnWmgucT2Kyqb41ntU5MYiBCtFUjPXP8gYGw8130_provenance.
• assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP669328.RA_yU6_drvMLaa4E_IwD16q1CFG_AaNQgCUiBOQgakloM130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669328.RA_yU6_drvMLaa4E_IwD16q1CFG_AaNQgCUiBOQgakloM130_provenance.
• assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP793858.RAA0gbQGWTXbJVI-PaOIxYgVLgRE-4erikeXAkwiLZ14A130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793858.RAA0gbQGWTXbJVI-PaOIxYgVLgRE-4erikeXAkwiLZ14A130_provenance.
• NP334086.RAhzDoMx1ZfwaJhdv21ALntLLoAdfhYpnBHUbZU4QblWA130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334086.RAhzDoMx1ZfwaJhdv21ALntLLoAdfhYpnBHUbZU4QblWA130_provenance.
• NP333994.RAEkTKOIjQPdlWp64q9SpW60uja8Vf-97dTuHKjX4VPNc130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333994.RAEkTKOIjQPdlWp64q9SpW60uja8Vf-97dTuHKjX4VPNc130_provenance.
• NP793859.RAEHQ9D18tzXwZb3S3G5Cv7nR61bI9iYar3kSpIhBaY_I130_assertion description "[This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793859.RAEHQ9D18tzXwZb3S3G5Cv7nR61bI9iYar3kSpIhBaY_I130_provenance.